… TP53-MT tumors, and differences between local and metastatic tumors. SCCA specimens
(n=… an extensive comprehensive genomic profiling with NGS and gene expression profiling for …

… from phase III trials testing anti-programmed cell-death-1/ligand-… for patients with
recurrent/metastatic HNSCC irrespective of PD-… , or metastatic cervical carcinoma, including cases …

… complete molecular characterization of this tumoral entity. In this context, we used genomic
profile … literature for aSCC in pre- and post-CRT for local and metastatic disease [25, 27, 28]. …

… The global standard treatment for advanced ASCC without distant metastasis is concurrent
… As reported in these clinical trials, the outcome of ASCC without distant metastatic lesions …

Anal squamous cell carcinoma (ASCC) is a rare neoplasm. Chemoradiotherapy is the
standard of care, with no therapeutic advances achieved over the past three decades. Thus, a …

… Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct … for
this malignancy and present with no metastasis. Demographic information related to the …

… Anal squamous cell carcinoma (ASCC) is a rare … Despite improved outcomes in non-metastatic
ASCC, definitive … of 79 non-metastatic ASCC patients with complete definitive …

… burden (TMB) and comprehensive genomic profiling by FoundationOne CDx. Tumour-…
metastatic sites, also because the number of metastatic samples was limited in this study. …

… In this study, exclusively using genome-wide methylation analyses, we sought to identify
comprehensive methylomic profiles that differentiated anal or cervical cancer from normal …

… the treatment of metastatic anal squamous cell carcinoma (9)… locoregional disease of anal
squamous cell carcinoma is still … have provided a comprehensive genomic profile of ACSCC. …